Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays

Journal of Molecular Histology

Volumn 43, Issue 3, 2012, Pages 297-306

  Zhang, Wenling ^a   Zeng, Zhaoyang ^a   Fan, Songqing ^b   Wang, Jieru ^c   Yang, Jianbo ^d   Zhou, Yanhong ^a   Li, Xiayu ^a   Huang, Donghai ^e   Liang, Fang ^a   Wu, Minghua ^a   Tang, Ke ^a   Cao, Li ^a   Li, Xiaoling ^a   Xiong, Wei ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Nasopharyngeal carcinoma (NPC); Prognosis; TGF superfamily type I receptor; TGFbR2; Tissue microarray(TMA)

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; VIRUS RNA;

ACTIVIN RECEPTOR LIKE KINASE 1 GENE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE IDENTIFICATION; GENETIC ASSOCIATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; ONCOGENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; TISSUE MICROARRAY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2 GENE;

ACTIVIN RECEPTORS, TYPE II; ANALYSIS OF VARIANCE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; RNA, VIRAL; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

HUMAN HERPESVIRUS 4;

EID: 84865626282     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-012-9392-4     Document Type: Article

References (48)

1. Albinana V, Sanz-Rodríguez F, Recio-Poveda L, Bernabéu C, Botella LM (2011) Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-b1 signaling in endothelial cells. Mol Pharmacol 79(5):833-843
2. Attisano L, Ca'rcamo J, Ventura F, Weis FM, Massagué J, Wrana JL (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75(4):671-680 (Pubitemid 23346366)
3. Carter KL, Cahir-McFarland E, Kieff E (2002) Epstein-Barr virus induced changes in B-lymphocyte gene expression. J Virol 76(20):10427-10436
4. Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765-1777 (Pubitemid 44664247)
5. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M, Zhang QH, Ou YJ, Zhuo HD, Fan S, Zhou YH, Li GY (2006) Defferential expression of Epstein-Barr virusencoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissuemicroarray analysis. Hum Pathol 37(5):593-605
6. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K (2008) Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 6:32
7. Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T, Kuwano H (2003) Reduced expression of transforming growth factor-b receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer 104(2): 161-166 (Pubitemid 36249790)
8. Garrigue-Antar L, Souza RF, Vellucci VF, Meltzer SJ, Reiss M (1996) Loss of transforming growth factor-b type II receptor gene expression in primary human esophageal cancer. Lab Invest 75(2):263-272 (Pubitemid 26272364)
9. Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD Jr, Page DL (2000) Loss of expression of transforming growth factor b type II receptor correlates with high tumour grade in human breast in situ and invasive carcinomas. Histopathology 36(2):168-177 (Pubitemid 30113980)
10. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endotheliumvia two distinct TGFbeta type I receptors. EMBO J 21(7):1743-1753 (Pubitemid 34614630)
11. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P (2003) Activin receptorlike kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12(4):817-828 (Pubitemid 37352776)
12. Gu Y, Jin P, Zhang L, Zhao X,GaoX,NingY,MengA,ChenYG(2006) Functional analysis of mutations in the kinase domain of the TGFb receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia. Blood 107(5):1951-1954 (Pubitemid 43289376)
13. Guo RJ, Wang Y, Kaneko E, Wang DY, Arai H, Hanai H, Takenoshita S, Hagiwara K, Harris CC, Sugimura H (1998) Analyses of mutation and loss of heterozygosity of coding sequences of the entire transforming growth factor b type II receptor gene in sporadic human gastric cancer. Carcinogenesis 19(9):1539-1544 (Pubitemid 28441854)
14. Heng DM, Wee J, Fong KW, Lian LG, Sethi VK, Chua ET, Yang TL, Khoo Tan HS, Lee KS, Lee KM, Tan T, Chua EJ (1999) Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86(10):1912-1920
15. Hong MH, Mai HQ, Min HQ, Ma J, Zhang EP, Cui NJ (2000) A comparison of the Chinese 1992 and fifth-edition international union against cancer staging systems for staging nasopharyngeal carcinoma. Cancer 89(2):242-247 (Pubitemid 30489869)
16. Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Tomita N, Ohue M, Hayakawa T (1997) Microsatellite instability and mutated type II transforming growth factor-b receptor gene in gliomas. Cancer Let 112(2):251-256 (Pubitemid 27104303)
17. Jones JO, Arvin AM (2003) Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J Virol 77(2):1268-1280 (Pubitemid 36055550)
18. Kawamata H, Furihata T, Omotehara F, Sakai T, Horiuchi H, Shinagawa Y, Imura J, Ohkura Y, Tachibana M, Kubota K, Terano A, Fujimori T (2003) Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray. Cancer Sci 94(8):699-706 (Pubitemid 37160927)
19. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C (1996) Loss of expression of transforming growth factor b type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 2(8):1255-1261 (Pubitemid 26299422)
20. Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C (1998) Loss of expression of transforming growth factor-b receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 4(7):1625-1630 (Pubitemid 28304723)
21. Kim WS, Park C, Hong SK, Park BK, Kim HS, Park K (2000) Microsatellite instability (MSI) in non-small cell lung cancer (NSCLC) is highly associated with transforming growth factor-b type II receptor (TGF-b RII) frameshift mutation. Anticancer Res 20(3A):1499-1502 (Pubitemid 30628156)
22. Lim CC, Yahaya H (2003) Second report of the national cancer registry cancer incidence in Malaysia. National Cancer Registry, Ministry of Health, Malaysia
23. Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomoto T, Weghorst CM (1998) Mutational analysis of the transforming growth factor b receptor type II gene in human ovarian carcinoma. Cancer Res 58(19):4227-4232 (Pubitemid 28450015)
24. Ma BB, Poon TC, To KF, Zee B, Mo FK, Chan CM, Ho S, Teo PM, Johnson PJ, Chan AT (2003) Prognostic significance of tumor angiogenesis, Ki67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma: A prospective study. Head Neck 25(10):864-872 (Pubitemid 37139899)
25. Ma BB, Leungm SF, Hui EP, Mo F, Kwan WH, Zee B, Yuen J, Chan AT (2004) Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer 101(4):776-781 (Pubitemid 39030934)
26. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B (1995) Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268(5215):1336-1338
27. McDermott AL, Dutt SN, Watkinson JC (2001) The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 26(2): 82-92 (Pubitemid 32368223)
28. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K (1995) A transforming growth factor b receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55(23):5545-5547
29. Nagai M, Kawarada Y, Watanabe M, Iwase T, Muneyuki T, Yamao K, Fukutome K, Yatani R (1999) Analysis of microsatellite instability, TGF-b type II receptor gene mutations and hMSH2 and hMLH1 allele losses in pancreaticobiliary maljunctionassociated biliary tract tumors. Anticancer Res 19(3A):1765-1768 (Pubitemid 29392735)
30. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B (1995) Microsatellite instability and mutations of the transforming growth factor b type II receptor gene in colorectal cancer. Cancer Res 55(23):5548-5550
31. Sakata K, Hareyama M, Tamakawa M, Oouchi A, Sido M, Nagakura H, Akiba H, Koito K, Himi T, Asakura K (1999) Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys 43(2):273-278 (Pubitemid 29091464)
32. Schneider J, Gonzalez-Roces S, Polla'n M, Lucas R, Tejerina A, Martin M, Alba A (2001) Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy. Breast Cancer Res 3(3):183-191 (Pubitemid 32390219)
33. Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptorlike kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682-689 (Pubitemid 37222165)
34. Shanmugaratnam K, Chan SH, de-Thé G, Goh JE, Khor TH, Simons MJ, Tye CY (1979) Histopathology of nasopharyngeal carcinoma: Correlations with epidemiology, survival rates and other biological characteristics. Cancer 44(3):1029-1044 (Pubitemid 10242239)
35. Taheri-Kadkhoda Z, Magnusson B, Svensson M, Mercke C, Björk-Eriksson T (2009) Expression modes and clinical manifestations of latent membrane protein1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma. Head Neck 31(4):482-492
36. Tani M, Takenoshita S, Kohno T, Hagiwara K, Nagamachi Y, Harris CC, Yokota J (1997) Infrequent mutations of the transforming growth factor b-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis 18(5):1119-1121 (Pubitemid 28132364)
37. Tatsumi-Tamori A, Yoshizaki T, Miwa T, Furukawa M (2000) Clinical evaluation of staging system for nasopharyngeal carcinoma: Comparison of fourth and fifth editions of UICC TNM classification. Ann Otol Rhinol Laryngol 109(12 Pt 1):1125-1129
38. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98(9):5116-5121 (Pubitemid 32397092)
39. Wang LF, Chai CY, Kuo WR, Tai CF, Lee KW, Ho KY (2006) The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma. Acta Otolaryngol 126(7):769-774
40. Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X (2006) Prognostic value of survivin and livin in nasopharyngeal carcinoma. Laryngoscope 116(1):126-130 (Pubitemid 44383976)
41. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, Deng H, Fan SQ, Li WF, Wang R, Zhou M, Zhu SG, Lü HB, Qian J, Zhang BC, Wang JR, Ma J, Xiao BY, Huang H, Zhang QH, Zhou YH, Luo XM, Zhou HD, Yang YX, Dai HP, Feng GY, Pan Q, Wu LQ, He L, Li GY (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64(6):1972-1974 (Pubitemid 38339442)
42. Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S, Chen L, Barlogie B, Shaughnessy JD Jr, Zhan F (2008) An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood 112(10):4235-4246
43. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, Liu H, Fan S, Qian J, Wang L, Li Z, Shen S, Li G (2006) Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 8(3):156-160
44. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, Cao L, Tang K, Qian J, Shen SR, Li GY (2007a) Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38(1):120-133 (Pubitemid 44880208)
45. Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, Li X, Fan S, Cao L, Tang K, Wu M, Li G (2007b) Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol 133(2):71-81 (Pubitemid 44950239)
46. Zeng Z, Huang H, Zhang W, Xiang B, Zhou M, Zhou Y, Ma J, Yi M, Li X, Li X, Xiong W, Li G (2011) Nasopharyngeal carcinoma: Advances in genomics and molecular genetics. Sci China Life Sci 54(10):966-975
47. Zhang HT, Chen XF, Wang MH, Wang JC, Qi QY, Zhang RM, Xu WQ, Fei QY, Wang F, Cheng QQ, Chen F, Zhu CS, Tao SH, Luo Z (2004) Defective expression of transforming growth factor b receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res 10(7):2359-2367 (Pubitemid 38445694)
48. Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K, Li G (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin 41(5):414-428